nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—A2M—optic choroid—glaucoma	0.156	0.627	CbGeAlD
Bacitracin—A2M—HDL-mediated lipid transport—ABCA1—glaucoma	0.0373	0.0833	CbGpPWpGaD
Bacitracin—A2M—eye—glaucoma	0.0314	0.126	CbGeAlD
Bacitracin—A2M—retina—glaucoma	0.0311	0.125	CbGeAlD
Bacitracin—A2M—connective tissue—glaucoma	0.0302	0.122	CbGeAlD
Bacitracin—A2M—HDL-mediated lipid transport—APOE—glaucoma	0.0246	0.0548	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—FAS—glaucoma	0.0215	0.0479	CbGpPWpGaD
Bacitracin—A2M—Lipoprotein metabolism—ABCA1—glaucoma	0.0214	0.0478	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—APOE—glaucoma	0.0197	0.044	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—BAD—glaucoma	0.0184	0.041	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—LTBP2—glaucoma	0.0165	0.0367	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—LTBP3—glaucoma	0.0165	0.0367	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.0143	0.0318	CbGpPWpGaD
Bacitracin—A2M—Lipoprotein metabolism—APOE—glaucoma	0.0141	0.0315	CbGpPWpGaD
Bacitracin—Pain—Dipivefrin—glaucoma	0.0138	0.0457	CcSEcCtD
Bacitracin—Vomiting—Physostigmine—glaucoma	0.0121	0.0399	CcSEcCtD
Bacitracin—Pain—Echothiophate—glaucoma	0.0116	0.0383	CcSEcCtD
Bacitracin—A2M—Platelet degranulation—TGFB2—glaucoma	0.0115	0.0257	CbGpPWpGaD
Bacitracin—Nausea—Physostigmine—glaucoma	0.0113	0.0373	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—COL11A1—glaucoma	0.0111	0.0248	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.011	0.0245	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—LOXL1—glaucoma	0.0102	0.0227	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—BCL2L1—glaucoma	0.0101	0.0226	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—APOE—glaucoma	0.00937	0.0209	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.00929	0.0207	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—TNF—glaucoma	0.00912	0.0203	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—ELN—glaucoma	0.00889	0.0198	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—SOD1—glaucoma	0.00872	0.0195	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.00831	0.0185	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—TP53—glaucoma	0.00804	0.0179	CbGpPWpGaD
Bacitracin—Pain—Carbachol—glaucoma	0.00691	0.0228	CcSEcCtD
Bacitracin—Pain—Levobunolol—glaucoma	0.0068	0.0225	CcSEcCtD
Bacitracin—Pain—Latanoprost—glaucoma	0.00631	0.0208	CcSEcCtD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP1—glaucoma	0.00611	0.0136	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—FN1—glaucoma	0.00607	0.0135	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.00578	0.0129	CbGpPWpGaD
Bacitracin—Rash—Metipranolol—glaucoma	0.00573	0.0189	CcSEcCtD
Bacitracin—Dermatitis—Metipranolol—glaucoma	0.00573	0.0189	CcSEcCtD
Bacitracin—Nausea—Metipranolol—glaucoma	0.0054	0.0178	CcSEcCtD
Bacitracin—Vomiting—Diclofenamide—glaucoma	0.00526	0.0174	CcSEcCtD
Bacitracin—Rash—Diclofenamide—glaucoma	0.00522	0.0172	CcSEcCtD
Bacitracin—Vomiting—Carbachol—glaucoma	0.00514	0.017	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.0051	0.0114	CbGpPWpGaD
Bacitracin—Rash—Carbachol—glaucoma	0.00509	0.0168	CcSEcCtD
Bacitracin—Dermatitis—Carbachol—glaucoma	0.00509	0.0168	CcSEcCtD
Bacitracin—Pain—Apraclonidine—glaucoma	0.00504	0.0167	CcSEcCtD
Bacitracin—Nausea—Carteolol—glaucoma	0.005	0.0165	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00496	0.0111	CbGpPWpGaD
Bacitracin—Nausea—Diclofenamide—glaucoma	0.00492	0.0162	CcSEcCtD
Bacitracin—Pain—Bimatoprost—glaucoma	0.00489	0.0161	CcSEcCtD
Bacitracin—Vomiting—Methazolamide—glaucoma	0.00485	0.016	CcSEcCtD
Bacitracin—Rash—Methazolamide—glaucoma	0.00481	0.0159	CcSEcCtD
Bacitracin—Dermatitis—Methazolamide—glaucoma	0.0048	0.0159	CcSEcCtD
Bacitracin—Nausea—Carbachol—glaucoma	0.0048	0.0158	CcSEcCtD
Bacitracin—Nausea—Levobunolol—glaucoma	0.00473	0.0156	CcSEcCtD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP2—glaucoma	0.00473	0.0105	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CA5A—glaucoma	0.00467	0.0104	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NARFL—glaucoma	0.00467	0.0104	CbGpPWpGaD
Bacitracin—Rash—Latanoprost—glaucoma	0.00465	0.0154	CcSEcCtD
Bacitracin—Dermatitis—Latanoprost—glaucoma	0.00465	0.0153	CcSEcCtD
Bacitracin—Nausea—Methazolamide—glaucoma	0.00453	0.0149	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—TGFB2—glaucoma	0.00443	0.00987	CbGpPWpGaD
Bacitracin—Pain—Brimonidine—glaucoma	0.00433	0.0143	CcSEcCtD
Bacitracin—Pain—Dorzolamide—glaucoma	0.00414	0.0137	CcSEcCtD
Bacitracin—Pain—Travoprost—glaucoma	0.00412	0.0136	CcSEcCtD
Bacitracin—Pain—Brinzolamide—glaucoma	0.00407	0.0134	CcSEcCtD
Bacitracin—Pain—Pilocarpine—glaucoma	0.00391	0.0129	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.00387	0.00863	CbGpPWpGaD
Bacitracin—Vomiting—Apraclonidine—glaucoma	0.00375	0.0124	CcSEcCtD
Bacitracin—Dermatitis—Apraclonidine—glaucoma	0.00372	0.0123	CcSEcCtD
Bacitracin—Rash—Bimatoprost—glaucoma	0.00361	0.0119	CcSEcCtD
Bacitracin—Dermatitis—Bimatoprost—glaucoma	0.0036	0.0119	CcSEcCtD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP9—glaucoma	0.00355	0.00792	CbGpPWpGaD
Bacitracin—Nausea—Apraclonidine—glaucoma	0.0035	0.0116	CcSEcCtD
Bacitracin—A2M—Platelet degranulation—VEGFA—glaucoma	0.00347	0.00775	CbGpPWpGaD
Bacitracin—Nausea—Bimatoprost—glaucoma	0.0034	0.0112	CcSEcCtD
Bacitracin—Vomiting—Acetazolamide—glaucoma	0.00335	0.0111	CcSEcCtD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.00331	0.00738	CbGpPWpGaD
Bacitracin—Rash—Brimonidine—glaucoma	0.00319	0.0105	CcSEcCtD
Bacitracin—Dermatitis—Brimonidine—glaucoma	0.00319	0.0105	CcSEcCtD
Bacitracin—Nausea—Acetazolamide—glaucoma	0.00313	0.0103	CcSEcCtD
Bacitracin—Pain—Clonidine—glaucoma	0.00312	0.0103	CcSEcCtD
Bacitracin—Vomiting—Dorzolamide—glaucoma	0.00308	0.0102	CcSEcCtD
Bacitracin—Rash—Dorzolamide—glaucoma	0.00305	0.0101	CcSEcCtD
Bacitracin—Dermatitis—Dorzolamide—glaucoma	0.00305	0.0101	CcSEcCtD
Bacitracin—Rash—Travoprost—glaucoma	0.00304	0.01	CcSEcCtD
Bacitracin—Dermatitis—Travoprost—glaucoma	0.00303	0.01	CcSEcCtD
Bacitracin—Vomiting—Brinzolamide—glaucoma	0.00302	0.00998	CcSEcCtD
Bacitracin—Nausea—Brimonidine—glaucoma	0.00301	0.00993	CcSEcCtD
Bacitracin—Rash—Brinzolamide—glaucoma	0.003	0.0099	CcSEcCtD
Bacitracin—Dermatitis—Brinzolamide—glaucoma	0.003	0.00989	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—LRP12—glaucoma	0.00296	0.00659	CbGpPWpGaD
Bacitracin—Vomiting—Pilocarpine—glaucoma	0.00291	0.00959	CcSEcCtD
Bacitracin—Rash—Pilocarpine—glaucoma	0.00288	0.00951	CcSEcCtD
Bacitracin—Dermatitis—Pilocarpine—glaucoma	0.00288	0.0095	CcSEcCtD
Bacitracin—Nausea—Dorzolamide—glaucoma	0.00287	0.00948	CcSEcCtD
Bacitracin—Nausea—Travoprost—glaucoma	0.00286	0.00944	CcSEcCtD
Bacitracin—Nausea—Brinzolamide—glaucoma	0.00282	0.00932	CcSEcCtD
Bacitracin—Pain—Betaxolol—glaucoma	0.00272	0.00897	CcSEcCtD
Bacitracin—Nausea—Pilocarpine—glaucoma	0.00271	0.00896	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—FN1—glaucoma	0.00269	0.006	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TGFB2—glaucoma	0.00263	0.00587	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP1—glaucoma	0.00256	0.00571	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—FN1—glaucoma	0.00234	0.00521	CbGpPWpGaD
Bacitracin—Vomiting—Clonidine—glaucoma	0.00232	0.00766	CcSEcCtD
Bacitracin—Rash—Clonidine—glaucoma	0.0023	0.0076	CcSEcCtD
Bacitracin—Dermatitis—Clonidine—glaucoma	0.0023	0.00759	CcSEcCtD
Bacitracin—A2M—Metabolism—CA1—glaucoma	0.00228	0.00508	CbGpPWpGaD
Bacitracin—Pain—Timolol—glaucoma	0.00222	0.00733	CcSEcCtD
Bacitracin—A2M—Metabolism—CTSA—glaucoma	0.00221	0.00492	CbGpPWpGaD
Bacitracin—Nausea—Clonidine—glaucoma	0.00217	0.00716	CcSEcCtD
Bacitracin—A2M—Metabolism—CA2—glaucoma	0.00208	0.00465	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—OPN4—glaucoma	0.00205	0.00457	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.00204	0.00454	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.00204	0.00454	CbGpPWpGaD
Bacitracin—Vomiting—Betaxolol—glaucoma	0.00202	0.00667	CcSEcCtD
Bacitracin—Rash—Betaxolol—glaucoma	0.002	0.00661	CcSEcCtD
Bacitracin—Dermatitis—Betaxolol—glaucoma	0.002	0.00661	CcSEcCtD
Bacitracin—A2M—Hemostasis—SOD1—glaucoma	0.00199	0.00445	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP2—glaucoma	0.00198	0.00442	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HEYL—glaucoma	0.00191	0.00425	CbGpPWpGaD
Bacitracin—Nausea—Betaxolol—glaucoma	0.00189	0.00623	CcSEcCtD
Bacitracin—A2M—Signaling Pathways—PTGFR—glaucoma	0.00185	0.00412	CbGpPWpGaD
Bacitracin—Vomiting—Timolol—glaucoma	0.00165	0.00545	CcSEcCtD
Bacitracin—Rash—Timolol—glaucoma	0.00164	0.0054	CcSEcCtD
Bacitracin—Dermatitis—Timolol—glaucoma	0.00164	0.0054	CcSEcCtD
Bacitracin—Nausea—Timolol—glaucoma	0.00154	0.00509	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.00154	0.00344	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—MMP1—glaucoma	0.00152	0.00339	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP9—glaucoma	0.00149	0.00332	CbGpPWpGaD
Bacitracin—A2M—Metabolism—TXN—glaucoma	0.00147	0.00327	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—CAV1—glaucoma	0.00146	0.00325	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RPTOR—glaucoma	0.00144	0.00322	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NCK2—glaucoma	0.0014	0.00312	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—FN1—glaucoma	0.00139	0.00309	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.00134	0.00299	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.00133	0.00296	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HDAC9—glaucoma	0.00119	0.00265	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTT1—glaucoma	0.00114	0.00254	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NOS3—glaucoma	0.0011	0.00246	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SMO—glaucoma	0.00093	0.00208	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000918	0.00205	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCA1—glaucoma	0.000907	0.00202	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP1B1—glaucoma	0.000907	0.00202	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NTRK2—glaucoma	0.000851	0.0019	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—VEGFA—glaucoma	0.000794	0.00177	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NGFR—glaucoma	0.00073	0.00163	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GSTM1—glaucoma	0.000725	0.00162	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NTRK1—glaucoma	0.000694	0.00155	CbGpPWpGaD
Bacitracin—A2M—Metabolism—MTHFR—glaucoma	0.000641	0.00143	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDKN2B—glaucoma	0.000639	0.00143	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EDN1—glaucoma	0.000613	0.00137	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TP53—glaucoma	0.0006	0.00134	CbGpPWpGaD
Bacitracin—A2M—Metabolism—APOE—glaucoma	0.000597	0.00133	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CAV1—glaucoma	0.000591	0.00132	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NGF—glaucoma	0.000564	0.00126	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—C3—glaucoma	0.000536	0.0012	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—APOE—glaucoma	0.000499	0.00111	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CAV1—glaucoma	0.000494	0.0011	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FN1—glaucoma	0.00047	0.00105	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BAD—glaucoma	0.000465	0.00104	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NOS3—glaucoma	0.000447	0.000997	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTGS2—glaucoma	0.000409	0.000912	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NOS3—glaucoma	0.000374	0.000834	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDKN1B—glaucoma	0.000324	0.000722	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MMP9—glaucoma	0.0003	0.000669	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—glaucoma	0.000269	0.000601	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TP53—glaucoma	0.000203	0.000454	CbGpPWpGaD
